Valuation GKB Ophthalmics Limited
Stocks
GKB
INE265D01015
Medical Equipment, Supplies & Distribution
|
Market Closed -
Bombay S.E.
13:02:31 13/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 64.39 INR | -6.83% |
|
+9.77% | +25.66% |
Company Valuation: GKB Ophthalmics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 413.3 | 463.7 | 547.2 | 439.6 | 304.1 | 264.6 |
| Change | - | 12.2% | 17.99% | -19.65% | -30.82% | -12.99% |
| Enterprise Value (EV) 1 | 363.7 | 423.1 | 518.2 | 382.4 | 319.7 | 337 |
| Change | - | 16.34% | 22.46% | -26.2% | -16.39% | 5.4% |
| P/E | -45.5x | 36.4x | -327x | -15.6x | -4.32x | 21.7x |
| PBR | 0.66x | 0.73x | 0.87x | 0.74x | 0.58x | 0.5x |
| PEG | - | -0x | 3x | -0x | -0x | -0x |
| Capitalization / Revenue | 0.73x | 0.65x | 0.72x | 0.5x | 0.28x | 0.18x |
| EV / Revenue | 0.64x | 0.6x | 0.69x | 0.43x | 0.29x | 0.23x |
| EV / EBITDA | 15.3x | 8.55x | 14.1x | 66.2x | -10.9x | 3.93x |
| EV / EBIT | -48.1x | 18.5x | 60.5x | -16.5x | -5.3x | 6.28x |
| EV / FCF | -38.7x | -25.6x | -8.45x | 15.9x | -6.64x | -13.3x |
| FCF Yield | -2.58% | -3.9% | -11.8% | 6.28% | -15.1% | -7.51% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.8 | 2.528 | -0.3321 | -5.58 | -13.98 | 2.417 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 568.8 | 709.4 | 754.7 | 882.5 | 1,090 | 1,491 |
| EBITDA 1 | 23.83 | 49.52 | 36.83 | 5.779 | -29.45 | 85.77 |
| EBIT 1 | -7.568 | 22.85 | 8.561 | -23.2 | -60.31 | 53.68 |
| Net income 1 | -9.075 | 12.74 | -1.674 | -28.1 | -70.45 | 12.18 |
| Net Debt 1 | -49.64 | -40.6 | -28.99 | -57.22 | 15.59 | 72.38 |
| Reference price 2 | 82.00 | 92.00 | 108.55 | 87.22 | 60.34 | 52.50 |
| Nbr of stocks (in thousands) | 5,041 | 5,041 | 5,041 | 5,041 | 5,041 | 5,041 |
| Announcement Date | 9/3/21 A | 9/7/22 A | 8/22/23 A | 7/25/24 A | 7/24/25 A | 7/30/26 A |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 3.71M | |
| 35.48x | 4.19x | 15.73x | 2.42% | 186B | |
| 21.86x | 3.71x | 13.29x | 2.81% | 124B | |
| 26.94x | 4.79x | 16.44x | 1.15% | 119B | |
| 31.57x | 3.04x | 12.28x | 2.26% | 91.43B | |
| 18.53x | 0.22x | 13.79x | 0.68% | 66.67B | |
| 43.97x | 3.87x | 13.18x | 1.94% | 58.76B | |
| 46.33x | 11.64x | 32.65x | -.--% | 54.99B | |
| 28.86x | 7.15x | 18.14x | 1.39% | 49.93B | |
| 52.13x | 1.44x | 13.34x | -.--% | 35.13B | |
| Average | 33.96x | 4.45x | 16.54x | 1.41% | 79B | |
| Weighted average by Cap. | 31.87x | 4.30x | 15.93x | 1.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GKB Stock
- Valuation GKB Ophthalmics Limited
Select your edition
All financial news and data tailored to specific country editions
